Calebin A Cartilage Protection via Inflammatory Modulation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Articular cartilage is prone to damage from trauma and disease, and existing treatments fail to effectively regenerate or protect it due to its limited cellular components, poor metabolism, and restricted chondrocyte division and migration within a dense matrix.

Innovation Solution

Calebin A and its compositions are administered in effective doses to protect mammalian articular cartilage from pathological damage, as demonstrated by its therapeutic potential in animal models with adjuvant-induced arthritis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for articular cartilage damage, then general wound healing mechanisms are activated, but the dense matrix fibers restrict chondrocyte division and migration preventing effective cartilage regeneration

Engineering Contradiction:

Improvecartilage regenerationVSAvoiddense matrix structure

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses Calebin A as a chemical intermediary that penetrates the dense cartilage matrix and mediates protection by modulating inflammatory pathways and preventing chondrocyte apoptosis, thereby overcoming the physical barrier of dense matrix fibers

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the biochemical parameters within the cartilage matrix by introducing Calebin A, which alters the inflammatory environment and cellular behavior, enabling protection and potential regeneration despite the dense matrix structure

Inventive Principle:

Principle #35Parameter changes

2Reliability

If articular cartilage is subjected to trauma or disease, then pathological damage occurs, but the tissue lacks sufficient cellular components and metabolic capacity for self-repair

Engineering Contradiction:

Improvecartilage protectionVSAvoidcellular components

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent enables the cartilage tissue to protect itself by using Calebin A to activate endogenous protective mechanisms, including inhibition of inflammatory enzymes and prevention of cell death, allowing the tissue to defend against pathological damage using its own cellular components

Inventive Principle:

Principle #25Self-service

3Ease of operation

If chondrocytes are restricted by dense matrix fibers, then division and migration capacity is limited, but this restriction prevents effective tissue repair

Engineering Contradiction:

Improvechondrocyte mobilityVSAvoidtissue repair capacity

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

Calebin A acts as a mediator that chemically modifies the microenvironment to protect chondrocytes, allowing them to maintain function and potentially repair tissue despite physical restrictions on movement and division imposed by the dense matrix

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentEP2893926B1Composition and method for the protection of articular cartilage

Publication Date: 2017.08.30 MAJEED MUHAMMED

Figure 1~2
Figure 3

AI summary

The novel therapeutic potential of Calebin A and compositions thereof to prevent pathological damage to mammalian articular cartilage is disclosed.